DNMT1 and laryngeal squamous cell carcinoma: Similarly, Wu [70] et al. showed that lncRNA H19 can promote the progression of laryngeal squamous cell carcinoma (LSCC) by targeting miR-148a and DNA methyltransferase DNMT1.